53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04563195 (ClinicalTrials.gov)	December 1, 2021	12/9/2020	BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome	BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome	Primary Sjogren's Syndrome	Drug: tibulizumab (LY3090106)	Matthew C. Baker	NULL	Not yet recruiting	18 Years	85 Years	All	12	Phase 2/Phase 3	United States